Fundz

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

PUBLIC · ACONFeb 06, 2024

Amount Raised

$3 Million

Round Type

Seed

BroomfieldOtherBiotechnologyHealthcareHealth Care

Description

Aclarion, Inc. completed several recent financing transactions, including raising just under $3M of gross proceeds and reducing outstanding non-convertible debt by $1.5M. The funds will assist in achieving key milestones, including initiating the CLARITY trial, onboarding additional KOL surgeons through the strategic partnership with Alphatec, and continuing to increase Nociscan orders.

Quick answer

Aclarion raised $3 Million in a Seed round, dated February 6, 2024. Aclarion is based in Broomfield, Colorado, United States.

How much did Aclarion raise?
Aclarion raised $3 Million in a Seed round on February 6, 2024.
What does Aclarion do?
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical..
Where is Aclarion based and how big is it?
Aclarion is based in Broomfield, Colorado, United States.
Who are the decision-makers at Aclarion?
Fundz holds 1 contact at Aclarion. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Aclarion that raised within 45 days of this round, from Fundz verified event records.

  • AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
  • Enliven Therapeutics raised $90M on March 21, 2024.
  • NewcelX raised $1.8M (Seed) on March 20, 2024.
  • Enliven Therapeutics raised $90M (Post-IPO Equity) on March 20, 2024.
  • Tessera Defense & Homeland Security Inc. raised $62M on March 15, 2024.
  • Alumis raised $259M (Series C) on March 7, 2024.

Who to call at Aclarion, and when

A new round usually means Aclarion is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aclarion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aclarion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aclarion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aclarion

Location

8181 ARISTA PLACE

Broomfield, Colorado, United States

About

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aclarion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts20 people are listed at Aclarion. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aclarion's next move

See what Strategic adds

Aclarion raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.